Opendata, web and dolomites

ProteinPlus SIGNED

Let's give the world appetite for health

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ProteinPlus project word cloud

Explore the words cloud of the ProteinPlus project. It provides you a very rough idea of what is the project "ProteinPlus" about.

create    capital    proved    ingredient    employees    50    medical    tastier    nutricia    designed    nanotechnology    protein    optimize    technological    levels    density    illness    10bn    ons    healthcare    ingredients    volume    nice    portion    reducing    overcomes    market    meet    manufacturers    sent    manufacture    copy    million    tons    supplements    commercial    barrier    mass    founded    disease    33    170bn    75m    proving    nutrition    nutritional    proteins    prevents    proof    fresenius    europeans    invented    reaching    savings    compliance    treatment    full    reduce    standards    dramatically    dense    oral    healthier    emulsar    bad    formulated    hundreds    launch    hyperproteinic    sizes    emulsion    revenues    half    casino    120    dominated    2020    validate    2004    public    patented    lab    burden    unilever    foods    generating    compatibility    gap    volumes    competitiveness    limiting    2012    specially    nestl    prepare    industrial    smart    transition    health    abbott    food    taste    induce    clinical    sustainability    leader    effectiveness    deficiencies    plus    disruptive    patients    eacute    malnutrition   

Project "ProteinPlus" data sheet

The following table provides information about the project.

Coordinator
EMULSAR 

Organization address
address: 26-28 rue Marius Aufan
city: Levallois-Perret
postcode: 92300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.emulsar.com/
 Total cost 2˙449˙800 €
 EC max contribution 1˙714˙860 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2016
 Duration (year-month-day) from 2016-09-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EMULSAR FR (Levallois-Perret) coordinator 1˙714˙860.00

Map

 Project objective

Disease-related malnutrition affects 33 million Europeans, a burden of 170bn€ for the EU. Oral Nutritional Supplements (ONS) are specially formulated foods designed to meet patients’ nutritional deficiencies during illness. This $10Bn ONS market is dominated by Nutricia, Nestlé, Fresenius & Abbott.

However, large portion sizes and bad taste in ONS induce very low levels of treatment compliance (50%), dramatically limiting effectiveness. Manufacturers face a technological barrier that prevents them from increasing protein density and thus reducing volume.

The aim of the project is to bring to the market a disruptive hyperproteinic ingredient – Protein Plus© - for ONS manufacturers, that overcomes this technology gap.

Founded in 2004, EMULSAR invented and patented its Smart Emulsion Nanotechnology© (SENT©), used to manufacture disruptive ingredients for health and nutrition. Since 2012, SENT© has produced hundreds of tons of food ingredients (used by Casino, Unilever…to create healthier & tastier products), proving its industrial sustainability and compatibility with commercial food standards.

In Phase 1, we proved (at lab-scale) that by applying SENT© to proteins, we can produce a protein-dense ingredient that makes it possible to reduce current ONS volumes by half.

Our Phase 2 objectives are to optimize our Protein Plus© ingredient, validate the industrial process, establish clinical proof of improved ONS compliance & prepare our market launch.

Our project will improve the competitiveness of ONS products, create public healthcare savings and enhance Europe’s health capital. For EMULSAR, the ONS market is the best path for becoming a European technology leader in health food, allowing EMULSAR to transition from nice-to-have applications (mass-market food) to must-have applications (medical nutrition). The current project is the key to reaching the full commercial potential of our nanotechnology, generating 75M€ in revenues & managing 120 employees by 2020.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROTEINPLUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROTEINPLUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

CGM (2018)

A next generation nano media tailored to capture and recycle hazardous micropollutants in contaminated industrial wastewater.

Read More  

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

STAR (2018)

Safe, Transparent, Active and Reliable mineral sunscreen technology

Read More